09.01.06
The U.S. Patent Office has issued Patent No. 7,045,155 to Novogen, Ltd. This patent, which Acatris, Minneapolis, MN, has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phytoestrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. Acatris has demonstrated diligence and in depth research to establish the scientifically-backed health benefits of SoyLife. SoyLife is a range of ingredients from soy germ, rich in isoflavones.